| Year |
Citation |
Score |
| 2011 |
Efe JA, Yuan X, Jiang K, Ding S. Development unchained: how cellular reprogramming is redefining our view of cell fate and identity. Science Progress. 94: 298-322. PMID 22026150 DOI: 10.3184/003685011X13131588500975 |
0.754 |
|
| 2011 |
Efe JA, Ding S. The evolving biology of small molecules: controlling cell fate and identity. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences. 366: 2208-21. PMID 21727126 DOI: 10.1098/Rstb.2011.0006 |
0.738 |
|
| 2011 |
Efe JA, Ding S. Reprogramming, transdifferentiation and the shifting landscape of cellular identity. Cell Cycle (Georgetown, Tex.). 10: 1886-7. PMID 21558807 DOI: 10.4161/Cc.10.12.15591 |
0.538 |
|
| 2011 |
Kim J, Efe JA, Zhu S, Talantova M, Yuan X, Wang S, Lipton SA, Zhang K, Ding S. Direct reprogramming of mouse fibroblasts to neural progenitors. Proceedings of the National Academy of Sciences of the United States of America. 108: 7838-43. PMID 21521790 DOI: 10.1073/Pnas.1103113108 |
0.643 |
|
| 2011 |
Efe JA, Hilcove S, Kim J, Zhou H, Ouyang K, Wang G, Chen J, Ding S. Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy. Nature Cell Biology. 13: 215-22. PMID 21278734 DOI: 10.1038/Ncb2164 |
0.568 |
|
| 2010 |
Abujarour R, Efe J, Ding S. Genome-wide gain-of-function screen identifies novel regulators of pluripotency. Stem Cells (Dayton, Ohio). 28: 1487-97. PMID 20629179 DOI: 10.1002/Stem.472 |
0.766 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2015 |
Rue SM, Eckelman BP, Efe JA, Bloink K, Deveraux QL, Lowery D, Nasoff M. Identification of a candidate therapeutic antibody for treatment of canine B-cell lymphoma. Veterinary Immunology and Immunopathology. 164: 148-59. PMID 25764941 DOI: 10.1016/J.Vetimm.2015.02.004 |
0.285 |
|
| 2005 |
Efe JA, Plattner F, Hulo N, Kressler D, Emr SD, Deloche O. Yeast Mon2p is a highly conserved protein that functions in the cytoplasm-to-vacuole transport pathway and is required for Golgi homeostasis. Journal of Cell Science. 118: 4751-64. PMID 16219684 DOI: 10.1242/Jcs.02599 |
0.285 |
|
| 2005 |
Shohdy N, Efe JA, Emr SD, Shuman HA. Pathogen effector protein screening in yeast identifies Legionella factors that interfere with membrane trafficking. Proceedings of the National Academy of Sciences of the United States of America. 102: 4866-71. PMID 15781869 DOI: 10.1073/Pnas.0501315102 |
0.284 |
|
| 2005 |
Efe JA, Botelho RJ, Emr SD. The Fab1 phosphatidylinositol kinase pathway in the regulation of vacuole morphology. Current Opinion in Cell Biology. 17: 402-8. PMID 15975782 DOI: 10.1016/J.Ceb.2005.06.002 |
0.277 |
|
| 2007 |
Efe JA, Botelho RJ, Emr SD. Atg18 regulates organelle morphology and Fab1 kinase activity independent of its membrane recruitment by phosphatidylinositol 3,5-bisphosphate. Molecular Biology of the Cell. 18: 4232-44. PMID 17699591 DOI: 10.1091/Mbc.E07-04-0301 |
0.273 |
|
| 2008 |
Botelho RJ, Efe JA, Teis D, Emr SD. Assembly of a Fab1 phosphoinositide kinase signaling complex requires the Fig4 phosphoinositide phosphatase. Molecular Biology of the Cell. 19: 4273-86. PMID 18653468 DOI: 10.1091/Mbc.E08-04-0405 |
0.233 |
|
| 2016 |
Weiskopf K, Anderson KL, Ito D, Schnorr PJ, Tomiyasu H, Ring AM, Bloink K, Efe J, Rue S, Lowery D, Barkal A, Prohaska S, McKenna KM, Cornax I, O'Brien TD, et al. Eradication of Canine Diffuse Large B-Cell Lymphoma in a Murine Xenograft Model with CD47 Blockade and Anti-CD20. Cancer Immunology Research. PMID 27856424 DOI: 10.1158/2326-6066.Cir-16-0105 |
0.229 |
|
| 2007 |
Emr SD, Efe J, Botelho R, Audhya J, Baird D, Stefan C. Phosphoinositide Lipid Signaling in the Regulation of Membrane Trafficking and Organelle Identity The Faseb Journal. 21. DOI: 10.1096/Fasebj.21.5.A37-B |
0.219 |
|
| Hide low-probability matches. |